HOBSCOTCH Research and Publications

Four people having a discussion at a table
Our publications summarize the findings of randomized-controlled trials with over 100 participants.


Our current research studies include:


HOBSCOTCH is scientifically proven to work. Our peer-reviewed publications document the efficacy of HOBSCOTCH and the methods from which the program draws.

Our publications also summarize the findings of randomized-controlled trials with over 100 participants, which demonstrated the ability of HOBSCOTCH to improve quality of life and aspects of attention and memory.

  • Caller TA, Secore KL, Ferguson RJ, Roth RM, Alexandre FP, Henegan PL, Harrington JJ, Jobst BC. Design and feasibility of a memory intervention with focus on self-management for cognitive impairment in epilepsy. Epilepsy & Behavior 44 (2015) 192-194.
  • Caller TA, Ferguson RJ, Roth RM, Secore KL, Alexandre FP, Zhao W, Tosteson TD, Henegan PL, Birney K, Jobst BC. A cognitive behavioral intervention (HOBSCOTCH) improves quality of life and attention in epilepsy. Epilepsy & Behavior 57 (2016) 111-117.
  • Jobst BC. Progress in Chronic Disease: Self-management for Patients With Epilepsy. Ann Intern Med. 2019;171(2):137-138.
  • Quon R, Andrew A, Schmidt S, Escoffery C, Schommer L, Chu F, Henninger H, Nagle K, Streltzov N, Jobst B. Self-management practices associated with quality of life for adults with epilepsy. J Neurol. 2019;266(11):2821-2828.
  • Camp EJ, Quon RJ, Sajatovic M, Briggs, F, Brownrigg B, Janevic M, Meisenhelter S, Steimel SA, Testorf ME, Kiriakopoulos, ET, Mazanec MT, Fraser R, Johnson EK, Jobst BC. Supervised machine learning to predict reduced depression severity in people with epilepsy through epilepsy self-management intervention. Epilepsy Behav. 2022;127:108548.
  • Streltzov NA, Schmidt SS, Schommer LM, Zhao W, Tosteson TD, Mazanec MT, Kiriakopoulos ET, Chu F, Henninger HL, Nagle K, Roth RM, Jobst B. Effectiveness of a Self-Management Program to Improve Cognition and Quality of Life in Epilepsy: A Pragmatic, Randomized, Multicenter Trial. Neurology. 2022;98(21): e2174-e2184.